Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB26FD4RC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,626
Award facts
- Contract value 100% obligated
- $4,625.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,625.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Botox 100 unit vials. The award, issued on October 30, 2025, with an ultimate completion date of November 21, 2025, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support the Department of Defense's recurring medical supply needs.
The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. As a critical pharmaceutical supplier within the federal military medical system, DMS Pharmaceutical Group supplies a comprehensive range of products including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to support Department of Defense healthcare operations worldwide. The company's established performance on numerous delivery orders across multiple therapeutic categories demonstrates its capability to fulfill the diverse and specialized pharmaceutical requirements of military healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DB26FD4RC?
SPE2DB26FD4RC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FD4RC worth?
The government has obligated $4,626 on SPE2DB26FD4RC.
Is contract SPE2DB26FD4RC an order under another contract?
Yes. SPE2DB26FD4RC is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB26FD4RC competed?
The extent of competition for SPE2DB26FD4RC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award